| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.19 | 8e-06 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.16 | 0.0005 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.17 | 0.0007 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.15 | 0.001 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.094 | 0.05 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.087 | 0.06 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.09 | 0.08 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.082 | 0.09 |